Citation: Ka. Prout et Aj. Larner, EMERGING THERAPEUTIC POSSIBILITIES IN PRION DISEASES - PATENTS 1993-1998, Expert opinion on therapeutic patents, 8(9), 1998, pp. 1099-1108
Authors:
JANSSEN JC
LARNER AJ
MORRIS H
BRONSTEIN AM
FARMER SF
Citation: Jc. Janssen et al., UPBEAT NYSTAGMUS - CLINICOANATOMICAL CORRELATION, Journal of Neurology, Neurosurgery and Psychiatry, 65(3), 1998, pp. 380-381
Citation: Aj. Larner et Mn. Rossor, ALZHEIMERS-DISEASE - TOWARDS THERAPEUTIC MANIPULATION OF THE AMYLOID PRECURSOR PROTEIN AND AMYLOID BETA-PEPTIDES, Expert opinion on therapeutic patents, 7(10), 1997, pp. 1115-1127
Citation: Aj. Larner, NEURITE GROWTH-INHIBITORY PROPERTIES OF AMYLOID BETA-PEPTIDES IN-VITRO - A-BETA-25-35, BUT NOT A-BETA-1-40, IS INHIBITORY, Neuroscience research communications, 20(3), 1997, pp. 147-155
Citation: Aj. Larner et al., MRI APPEARANCES IN SUBACUTE COMBINED DEGENERATION OF THE SPINAL-CORD DUE TO VITAMIN-B12 DEFICIENCY, Journal of Neurology, Neurosurgery and Psychiatry, 62(1), 1997, pp. 99-100
Citation: Aj. Larner et al., ARRESTED PROGRESSION OF THE CAUDA-EQUINA SYNDROME OF ANKYLOSING-SPONDYLITIS AFTER LUMBOPERITONEAL SHUNTING, Journal of Neurology, Neurosurgery and Psychiatry, 61(1), 1996, pp. 115-116
Citation: Aj. Larner, THE CORTICAL NEURITIC DYSTROPHY OF ALZHEIMERS-DISEASE - NATURE, SIGNIFICANCE, AND POSSIBLE PATHOGENESIS, Dementia, 6(4), 1995, pp. 218-224
Citation: Aj. Larner et M. Anderson, RASMUSSENS SYNDROME - PATHOGENETIC THEORIES AND THERAPEUTIC STRATEGIES, Journal of neurology, 242(6), 1995, pp. 355-358
Citation: Aj. Larner, PHYSIOLOGICAL AND PATHOLOGICAL INTERRELATIONSHIPS OF AMYLOID-BETA PEPTIDE AND THE AMYLOID PRECURSOR PROTEIN, BioEssays, 17(9), 1995, pp. 819-824